Literature DB >> 26929415

Pulmonary hypertension.

Anton Vonk Noordegraaf1, Joanne A Groeneveldt2, Harm Jan Bogaard2.   

Abstract

In 2015, more than 800 papers were published in the field of pulmonary hypertension. A Clinical Year in Review article cannot possibly incorporate all this work and needs to be selective. The recently published European guidelines for the diagnosis and treatment of pulmonary hypertension contain an inclusive summary of all published clinical studies conducted until very recently. Here, we provide an overview of papers published after the finalisation of the guideline. In addition, we summarise recent advances in pulmonary vasculature science. The selection we made from the enormous amount of published work undoubtedly reflects our personal views and may not include all papers with a significant impact in the near or more distant future. The focus of this paper is on the diagnosis of pulmonary arterial hypertension, understanding the success of combination therapy on the right ventricle and scientific breakthroughs.
Copyright ©ERS 2016.

Entities:  

Mesh:

Year:  2016        PMID: 26929415     DOI: 10.1183/16000617.0096-2015

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  15 in total

Review 1.  Calcium-sensing receptor in the development and treatment of pulmonary hypertension.

Authors:  Ming-Yuan Zhou; Lin Cheng; Lei Chen; Ying-Jian Gu; Yun Wang
Journal:  Mol Biol Rep       Date:  2021-01-04       Impact factor: 2.316

Review 2.  The role of ferroptosis in endothelial cell dysfunction.

Authors:  Wei Yuan; Hao Xia; Yao Xu; Chong Xu; Nan Chen; Chen Shao; Zhiyin Dai; Rui Chen; Aibin Tao
Journal:  Cell Cycle       Date:  2022-06-14       Impact factor: 5.173

Review 3.  Oxidative Stress and Antioxidative Therapy in Pulmonary Arterial Hypertension.

Authors:  Dan Xu; Ya-Hui Hu; Xue Gou; Feng-Yang Li; Xi-Yu-Chen Yang; Yun-Man Li; Feng Chen
Journal:  Molecules       Date:  2022-06-09       Impact factor: 4.927

Review 4.  Multifaceted Roles of Ferroptosis in Lung Diseases.

Authors:  Yi Li; Ying Yang; Yongfeng Yang
Journal:  Front Mol Biosci       Date:  2022-06-24

Review 5.  Treatment strategies for the right heart in pulmonary hypertension.

Authors:  Berend E Westerhof; Nabil Saouti; Willem J van der Laarse; Nico Westerhof; Anton Vonk Noordegraaf
Journal:  Cardiovasc Res       Date:  2017-10-01       Impact factor: 10.787

Review 6.  Extracellular vesicles: novel communicators in lung diseases.

Authors:  Aradhana Mohan; Stuti Agarwal; Matthias Clauss; Nicholas S Britt; Navneet K Dhillon
Journal:  Respir Res       Date:  2020-07-08

7.  MiR-629 regulates hypoxic pulmonary vascular remodelling by targeting FOXO3 and PERP.

Authors:  Mei Zhao; Ni Chen; Xuelian Li; Ling Lin
Journal:  J Cell Mol Med       Date:  2019-06-26       Impact factor: 5.310

8.  The value of cardiopulmonary exercise testing in the diagnosis of pulmonary hypertension.

Authors:  Qin Luo; Xue Yu; Zhihui Zhao; Qing Zhao; Xiuping Ma; Qi Jin; Lu Yan; Yi Zhang; Zhihong Liu
Journal:  J Thorac Dis       Date:  2021-01       Impact factor: 2.895

9.  Acupuncture combined with western medicine for the treatment of hypertension: A protocol for an updated systematic review and meta-analysis.

Authors:  Si-Han Wang; Jia-Tuo Xu; Xiao-Juan Hu; Ji Cui
Journal:  Medicine (Baltimore)       Date:  2021-06-25       Impact factor: 1.889

10.  Long-Chain Non-Coding RNA Metastasis-Related Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes the Proliferation and Migration of Human Pulmonary Artery Smooth Muscle Cells (hPASMCs) by Regulating the MicroRNA-503 (miR-503)/Toll-Like Receptor 4 (TLR4) Signal Axis.

Authors:  Meng He; Juxin Shen; Chunyi Zhang; Yefeng Chen; Weisi Wang; Kelong Tao
Journal:  Med Sci Monit       Date:  2020-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.